Shenzhen Salubris Pharmaceuticals Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 1,090.97 million compared to CNY 887.51 million a year ago. Revenue was CNY 1,090.97 million compared to CNY 887.51 million a year ago.

Net income was CNY 200.27 million compared to CNY 210.95 million a year ago. Basic earnings per share from continuing operations was CNY 0.18 compared to CNY 0.19 a year ago. Diluted earnings per share from continuing operations was CNY 0.18 compared to CNY 0.19 a year ago.